University of Minnesota receives seed funding for clinical study of metformin to treat, prevent COVID-19
MINNEAPOLIS, MN- September 25, 2020 – University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19. To prevent delay during the COVID-19 pandemic, the California-based Parsemus Foundation is funding the University…